FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileFirst Trust Nasdaq Pharmaceuticals ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
FTXH
First Trust Nasdaq Pharmaceuticals ETF ETF AnalysisComprehensive ETF analysis for First Trust Nasdaq Pharmaceuticals ETF (FTXH) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisFTXH
FTXH
First Trust Nasdaq Pharmaceuticals ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
FTXH
  1. Home
  2. Screener
  3. First Trust Nasdaq Pharmaceuticals ETFFTXHETF

First Trust Nasdaq Pharmaceuticals ETF

ETF
🇺🇸FTXH•NASDAQ•Sector Equity
Fund size (USD)
$1.20B
Expense Ratio
0.6%
Yield (12 mo)
0.67%
Holdings
50

Your view on FTXH

First Trust Nasdaq Pharmaceuticals ETF

ETFFirst Trust
🇺🇸FTXH•NASDAQ•Sector Equity
Fund size (USD)
$1.20B
Expense Ratio
0.6%
Yield (12 mo)
0.67%
Holdings
50
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a Sector Equity fund from First Trust, listed since 2016, with $1.2B in assets under management, a 0.60% expense ratio and a NAV of $44.24 USD.

Overview for First Trust Nasdaq Pharmaceuticals ETF

Fund Type
ETF
Fund Issuer
First Trust
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
September 20, 2016
Domicile
US
Website
ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH
Fund Type
ETF
Fund Issuer
First Trust
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
September 20, 2016
Domicile
US
Website
ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH
Fund Type
ETF
Fund Issuer
First Trust
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
September 20, 2016
Domicile
US
Website
ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH

About this fund

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals …

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Sector Equity

Expense Ratio

0.6%

Yield (12 mo)

0.67%

Fund size

$1.20B

Fund Details

NAV$44.24 USD
Holdings50
Average Volume507.7K
Inception DateSeptember 20, 2016
Asset ClassSector Equity
Fund IssuerFirst Trust
DomicileUS
ISINUS33738R8372
CUSIP33738R837
NAV CurrencyUSD

Expense Ratio

0.6%

Dividend Yield (TTM)

0.67%

Assets Under Management

$1.20B

NAV

$44.24 USD

Holdings

50

Average Volume

507.7K

Inception Date

September 20, 2016

Asset Class

Sector Equity

Fund Issuer

First Trust

Domicile

US

ISIN

US33738R8372

CUSIP

33738R837

NAV Currency

USD

Expense Ratio

0.6%

Dividend Yield (TTM)

0.67%

Assets Under Management

$1.20B

NAV

$44.24 USD

Holdings

50

Average Volume

507.7K

Inception Date

September 20, 2016

Asset Class

Sector Equity

Fund Issuer

First Trust

Domicile

US

ISIN

US33738R8372

CUSIP

33738R837

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 24, 2026Sep 30, 2026$0.0113
Jun 25, 2026Jun 30, 2026$0.092
Mar 26, 2026Mar 31, 2026$0.0573
Dec 12, 2025Dec 31, 2025$0.1294
Total, 12 months$0.29 a share

Dividend yield (TTM) 0.67% = $0.29 paid per share in the 12 months to Nov 20, 2026 ÷ the $43.04 price. Past distributions; future payments can differ.

Data last updated: Nov 15, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

51 positions
1LLYEli Lilly and Company
8.23%
2ABBVAbbVie Inc.
7.79%
3JNJJohnson & Johnson
7.08%
4PFEPfizer Inc.
6.82%
5MRKMerck & Co., Inc.
6.33%
6VTRSViatris Inc.
4.24%
7REGNRegeneron Pharmaceuticals, Inc.
4.07%
8BIIBBiogen Inc.
4.02%
9GILDGilead Sciences, Inc.
4.01%
10ZTSZoetis Inc.
3.69%
11AMGNAmgen Inc.
3.59%
12UTHRUnited Therapeutics Corporation
3.42%
13VRTXVertex Pharmaceuticals Incorporated
3.37%
14INCYIncyte Corporation
3.27%
15BMYBristol-Myers Squibb Company
3.07%

Concentration

Top 10 Weight56.26%
1LLYEli Lilly and Company
8.23%
2ABBVAbbVie Inc.
7.79%
3JNJJohnson & Johnson
7.08%
4PFEPfizer Inc.
6.82%
5MRKMerck & Co., Inc.
6.33%
6VTRSViatris Inc.
4.24%
7REGNRegeneron Pharmaceuticals, Inc.
4.07%
8BIIBBiogen Inc.
4.02%
9GILDGilead Sciences, Inc.
4.01%
10ZTSZoetis Inc.
3.69%
11AMGNAmgen Inc.
3.59%
12UTHRUnited Therapeutics Corporation
3.42%
13VRTXVertex Pharmaceuticals Incorporated
3.37%
14INCYIncyte Corporation
3.27%
15BMYBristol-Myers Squibb Company
3.07%

Top 10 Weight

56.26%

1LLYEli Lilly and Company
8.23%$87.09M
2ABBVAbbVie Inc.
7.79%$82.44M
3JNJJohnson & Johnson
7.08%$74.92M
4PFEPfizer Inc.
6.82%$72.15M
5MRKMerck & Co., Inc.
6.33%$67.01M
6VTRSViatris Inc.
4.24%$44.89M
7REGNRegeneron Pharmaceuticals, Inc.
4.07%$43.07M
8BIIBBiogen Inc.
4.02%$42.52M
9GILDGilead Sciences, Inc.
4.01%$42.42M
10ZTSZoetis Inc.
3.69%$39.06M
11AMGNAmgen Inc.
3.59%$38.06M
12UTHRUnited Therapeutics Corporation
3.42%$36.25M
13VRTXVertex Pharmaceuticals Incorporated
3.37%$35.64M
14INCYIncyte Corporation
3.27%$34.66M
15BMYBristol-Myers Squibb Company
3.07%$32.55M

Top 10 Weight

56.26%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on19 funds
FundAsset classExpense ratioAssetsHoldings
FTXHFirst Trust Nasdaq Pharmaceuticals ETFThis fundSector Equity0.60%$1.2B50

Comparable funds

  • FTXGFirst Trust Nasdaq Food & Beverage ETFSector Equity0.60%$39M30
  • HECAHedgeye Capital Allocation ETFAsset allocation0.81%$196M0
  • JCHIJPMorgan Active China ETFInternational Equity0.65%$15M53
  • LSTLeuthold Select Industries ETFEquity0.65%$216M120
  • OVSOverlay Shares Small Cap Equity ETFEquity0.83%$44M11
  • PEMXPutnam Emerging Markets Ex-China ETFEquity0.71%$29M59
  • RNEMEmerging Markets Equity Select ETFEmerging Markets Equity0.75%$17M285

More First Trust ETFs

  • MDEVFirst Trust Indxx Medical Devices ETFSector Equity0.70%$3M50
  • MDIVMulti-Asset Diversified Income Index FundMulti-Asset0.83%$417M123
  • MFLXFirst Trust Flexible Municipal High Income ETFMunicipal Bond0.49%$20M76
  • MGOVFirst Trust Intermediate Government Opportunities ETFFixed Income0.50%$92M199
  • MISLFirst Trust Indxx Aerospace & Defense ETFSector Equity0.60%$527M44
  • MMSCFirst Trust Multi-Manager Small Cap Opportunities ETFSmall/Micro Cap Equity0.95%$51M190
  • NFTYFirst Trust India NIFTY 50 Equal Weight ETFInternational Equity0.80%$109M50
  • NTRLFirst Trust Merger Arbitrage ETFAlternatives0.95%$17M9
  • NXTGFirst Trust Indxx NextG ETFSector Equity0.70%$505M98
  • PMTLFIRST TRUST INDXX QUALITY PRECIOUS METALS MINERS ETFSector & Industry0.65%$2M75
  • QABAFirst Trust NASDAQ ABA Community Bank Index FundSector Equity0.63%$88M158
  • QCLNFirst Trust NASDAQ Clean Edge Green Energy Index FundSector Equity0.59%$479M57
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.